We are searching for a creative and experienced biologist to work in the laboratory and be responsible for leading our neurodegeneration program which is focused on developing therapies to treat severe neurodegenerative disease related to the loss of function and or toxic aggregation of proteins in neural diseases such as ALS, Alzheimer’s, Parkinson’s, and FTD. The ideal candidate will be experienced in pharmaceutical drug discovery and fluent in in vitro biochemical and cell-based assay development as well as in vivo pharmacology models with hands-on experience in high content imaging, immunohistochemistry, RT- and qPCR, animal dosing and sample collection, and neural anatomical analyses.
You will be responsible for helping to develop the strategy for our discovery program from screening to preclinical proof of concept. A thorough knowledge of disease-relevant functional cellular and pharmacologic assays and models is essential. You will work closely with cross-functional teams to further the discovery efforts.
In this position you’ll be part of an energizing and supportive startup culture engaged in continuous learning, and part of an exceptional international team. This role is based at our site in Boston's Seaport district. Dewpoint offers competitive salary and benefits.
Ph.D. in neuroscience, biochemistry, molecular biology, cell biology or a related field
5+ years’ experience with neurodegeneration cellular, biochemical assay development and in vivo pharmacological models
Demonstrated strategic and tactical ability to lead a neurodegeneration project discovery teams in a pharmaceutical or biotech company setting
Strong attention to detail, ability to balance multiple objectives
Strong communication skills.
Ability to collaborate in a multidisciplinary and dynamic environment and experience in mentoring and leading scientific teams
Ability to communicate effectively in English, the shared language of our multicultural team
Experience with matrix reporting structures
Experience in clinical candidate selection and writing study reports and Investigature Brochures for regulatory submissions